| 2018年
12月31日 | 2019年
12月31日 | 2020年
12月31日 | 2021年
12月31日 | 2022年
12月31日 | 2023年
12月31日 | 2024年
12月31日 |
|---|
| Income (loss) from continuing operations | - | - | - | - | -3,091 | -1,869 | 3,692 |
|---|
| Depreciation and amortization | 963 | 1,503 | 1,517 | 1,716 | 1,778 | 1,834 | 2,006 |
|---|
| Depreciation and depletion of biological assets | - | - | - | 1,030 | 1,214 | 1,391 | 1,518 |
|---|
| Result on disposal of property, plant and equipments, investment and intangible | 51 | -15 | -40 | 141 | -4 | 63 | 164 |
|---|
| Provision for tax, civil and labor risks | - | - | - | -116 | -341 | -271 | -1,349 |
|---|
| Income from investments under the equity method | - | - | - | - | -1 | 3 | 14 |
|---|
| Financial results, net | 2,242 | -1,865 | -1,699 | -3,045 | -2,669 | -2,821 | -1,791 |
|---|
| Deferred income tax | - | -290 | -250 | -808 | 208 | -244 | 8 |
|---|
| Other | - | - | - | - | - | - | 808 |
|---|
| Cash flow provided by operating activities before working capital | - | - | - | 5,669 | 3,683 | 3,984 | 11,022 |
|---|
| Trade accounts and notes receivables | 993 | -182 | -481 | 387 | -145 | -607 | -15 |
|---|
| Inventories | -226 | -131 | -2,623 | -2,879 | 713 | 1,962 | 546 |
|---|
| Biological assets - current | - | - | - | -816 | -297 | 385 | -134 |
|---|
| Trade accounts payable | -1,051 | -393 | 2,155 | 1,420 | -523 | -3,295 | -1,156 |
|---|
| Cash generated by operating activities | - | - | - | 4,572 | 2,588 | 2,429 | 10,264 |
|---|
| Redemptions (investments) in securities at FVTPL | - | - | - | 145 | 680 | 19 | 273 |
|---|
| Interest received | - | - | - | - | 282 | 456 | 924 |
|---|
| Dividends and interest on shareholders' equity received | - | - | - | - | - | -1 | - |
|---|
| Payment of tax, civil and labor provisions | - | - | - | -399 | -292 | -398 | -261 |
|---|
| Derivative financial instruments | - | - | -924 | -266 | 1,191 | 238 | 154 |
|---|
| Other operating assets and liabilities | -265 | -97 | 24 | -652 | 487 | 1,672 | -268 |
|---|
| Net cash provided by operating activities | 296 | 2,521 | 4,418 | 3,924 | 1,876 | 3,939 | 10,777 |
|---|
| Redemption (additions) on investments in securities at amortized cost | - | - | - | 4 | 289 | 61 | -36 |
|---|
| Investments in securities at FVTOCI | - | - | - | - | - | - | -887 |
|---|
| Redemption of restricted cash | -249 | 356 | 286 | 0 | -2 | 13 | -258 |
|---|
| Additions to property, plant and equipment | 578 | 417 | 805 | 1,555 | 1,453 | 792 | 810 |
|---|
| Additions to biological assets - non-current | 845 | 838 | 1,006 | 1,240 | 1,388 | 1,457 | 1,454 |
|---|
| Proceeds from disposals of property, plant, equipments and investment | 262 | 215 | 127 | 59 | 63 | 168 | 78 |
|---|
| Additions to intangible | 21 | 64 | 96 | 180 | 229 | 168 | 159 |
|---|
| Business combination, net of cash | - | - | - | 986 | 158 | - | - |
|---|
| Capital increase in affiliates | - | - | - | - | 93 | 1 | 45 |
|---|
| Capital increase in subsidiaries | - | - | - | - | - | -184 | - |
|---|
| Net cash used in investing activities | -1,416 | 1,443 | -1,431 | -3,549 | -3,259 | -2,114 | -3,499 |
|---|
| Proceeds from debt issuance | 6,500 | 5,399 | 10,420 | 2,991 | 3,393 | 3,836 | 2,345 |
|---|
| Repayment of debt | 6,224 | 9,481 | 10,247 | 1,395 | 3,984 | 6,890 | 3,986 |
|---|
| Payment of interest | - | - | - | 1,193 | 1,518 | 1,680 | 1,677 |
|---|
| Payment of interest derivatives - fair value hedge | - | - | - | 3 | 253 | 699 | 110 |
|---|
| Capital increase through issuance of shares | - | - | - | - | 5,275 | 5,313 | - |
|---|
| Treasury shares acquisition | - | - | - | - | - | - | 1,288 |
|---|
| Dividends and interests on shareholders' equity paid | - | - | - | - | - | - | 1,144 |
|---|
| Acquisition of non-controlling interests | - | - | - | 238 | 7 | - | - |
|---|
| Payment of lease liabilities | - | 553 | 554 | 705 | 650 | 742 | 866 |
|---|
| Net cash provided (used in) financing activities | 174 | -4,819 | -587 | -572 | 2,256 | -862 | -6,727 |
|---|
| Effect of exchange rate variation on cash and cash equivalents | 72 | 55 | 939 | 150 | -271 | 170 | 1,350 |
|---|
| Net increase (decrease) in cash and cash equivalents | -975 | -798 | 3,339 | -48 | 602 | 1,134 | 1,901 |
|---|